SARS-CoV-2COVID-19:

Laban Kato1, Jackson Sembera2, Gerald Kevin Oluka1,2

  • 1Viral Pathogens Research Theme, Medical Research Council, Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine (MRC/UVRI & LSHTM) Research Unit, Entebbe 49, Uganda.

Vaccines
|May 7, 2025
PubMed
概括

地理位置显著影响SARS-CoV-2 (COVID-19) 抗体反应,乌干达参与者与英国参与者持续反应相比,显示出快速但短暂的免疫力. 这凸显了对特定区域的疫苗接种战略的需要.